Oncology in Clinical Practice

Oncology in Clinical Practice Dane kontaktowe, mapa i wskazówki, formularz kontaktowy, godziny otwarcia, usługi, oceny, zdjęcia, filmy i ogłoszenia od Oncology in Clinical Practice, Zdrowie i medycyna, Ulica Roentgena 5, Warsaw.

Can routine blood tests help predict outcomes in small cell lung cancer? This retrospective study of 378 SCLC patients f...
29/01/2026

Can routine blood tests help predict outcomes in small cell lung cancer? This retrospective study of 378 SCLC patients found that thrombocytosis in limited-disease SCLC (LD-SCLC) and anemia in extended-disease SCLC (ED-SCLC) were linked to poorer response to chemotherapy, highlighting the potential predictive/prognostic value of baseline complete blood count (CBC) parameters.

Authors: Faruk Tas, Akin Ozturk, Kayhan Erturk

Which patients with HER2-positive breast cancer are most likely to achieve pathological complete response (pCR) after ne...
09/01/2026

Which patients with HER2-positive breast cancer are most likely to achieve pathological complete response (pCR) after neoadjuvant therapy? In this prospective study (n = 174), HER2 IHC score 3+, high Ki-67 (> 38%), and PR negativity were associated with higher pCR rates — supporting more personalized, biomarker-informed treatment planning.
Authors: Heba M. Sami, Mervat M. El Deftar, Marwa N. Abd Al-Hafez, Marwa M. Selim, Heba M. El-Zawahry

This case report describes a patient with metastatic pancreatic cancer and a germline BRCA2 mutation who achieved a comp...
07/01/2026

This case report describes a patient with metastatic pancreatic cancer and a germline BRCA2 mutation who achieved a complete, durable response to maintenance olaparib after platinum-based chemotherapy. As of June 2025, after 20 months, the patient remains in remission with good quality of life, highlighting the value of molecular testing and targeted therapy.

Authors: Agata I. Adamczuk-Nurzyńska, Paweł Nurzyński, Artur Sankowski

This retrospective analysis evaluated acute and late toxicities of postoperative adjuvant IMRT with a simultaneous integ...
29/12/2025

This retrospective analysis evaluated acute and late toxicities of postoperative adjuvant IMRT with a simultaneous integrated boost (IMRT-SIB) in oral cavity squamous cell carcinoma (SCCHN) patients. Toxicities were mostly grade 1–2, with no grade ≥ 3 events; late xerostomia/dysphagia/hoarseness were generally mild and improved over time. The findings support parotid-sparing IMRT to reduce long-term xerostomia and help preserve quality of life.
Authors: Siddharth Arora, Kriti Grover, Prarabdh Singh, Nitesh Mohan

With the expected growth in cancer incidence, screening programs and early diagnosis are of great importance. Novel digi...
17/12/2025

With the expected growth in cancer incidence, screening programs and early diagnosis are of great importance. Novel digital, internet-based methods have the potential to increase awareness among patients, boosting early detection rates. This review paper focuses on how awareness of cancer screening programs can be disseminated via the internet and social media platforms, including mHealth and web-based education.

Authors: Muazez Küçükkaya, Esma Demirezen

This exceptional case report — a woman living disease-free 47 years after Ewing sarcoma treatment — highlights why lifel...
15/12/2025

This exceptional case report — a woman living disease-free 47 years after Ewing sarcoma treatment — highlights why lifelong follow-up is essential in long-term survivors, due to the risk of late relapse, secondary neoplasms, and pathological fractures (including around major biological events such as pregnancy).

Authors: Piotr Remiszewski, Maryna Rubach, Anna M. Czarnecka
📖 Read the full article: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/108264

A remarkable long-term remission in advanced NSCLC: this case report presents a 52-year-old patient who, after relapse w...
10/12/2025

A remarkable long-term remission in advanced NSCLC: this case report presents a 52-year-old patient who, after relapse with a solitary brain metastasis, achieved a durable complete response to nivolumab following stereotactic radiosurgery and systemic therapy.
Authors: Monika Żeleźnicka, Joanna Filipow, Filip Grydź, Tomasz Sarosiek
Read the full case report at:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/107065

This recent systematic review summarizes toripalimab’s mechanism of action, clinical activity and safety profile in pati...
09/12/2025

This recent systematic review summarizes toripalimab’s mechanism of action, clinical activity and safety profile in patients with esophageal squamous cell carcinoma (ESCC). Across randomized clinical trials, toripalimab combined with chemotherapy improved survival and pathological responses, with manageable toxicity—supporting its growing role in ESCC management.

Authors: Natalia Picheta, Julia Piekarz, Katarzyna Szklener
📖 Read the full article:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/107560/

Cognitive impairment is common in older adults with cancer and can have impact on anti-cancer therapy. This study identi...
02/12/2025

Cognitive impairment is common in older adults with cancer and can have impact on anti-cancer therapy. This study identifies depression, lower education, and reduced handgrip strength as key risk factors, emphasizing the need for early cognitive screening in geriatric oncology.

Authors: Teodoro J. Oscanoa, Edwin Cieza-Macedo, Roman Romero-Ortuno
📄 Full text available at:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/107861

Histological transformation is a known mechanism of resistance to EGFR-TKIs in NSCLC. This case report presents a transf...
26/11/2025

Histological transformation is a known mechanism of resistance to EGFR-TKIs in NSCLC. This case report presents a transformation from non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) during osimertinib therapy, with persistence of the original EGFR mutation. It underscores the importance of re-biopsy to determine resistance mechanisms and guide further treatment strategies.
Authors: Aleksandra Łomża-Łaba, Natalia Krzyżanowska, Magdalena Wójcik-Superczyńska, Iwona Paśnik, Jarosław Buczkowski, Paweł Krawczyk, Janusz Milanowski
📖 Read the full article: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/104391

Could the gut microbiome influence chemoimmunotherapy outcomes in small-cell lung cancer patients?In this case study of ...
24/11/2025

Could the gut microbiome influence chemoimmunotherapy outcomes in small-cell lung cancer patients?
In this case study of two SCLC patients with markedly different outcomes, higher microbiome diversity and greater abundance of bacterial families such as Lachnospiraceae and Akkermansiaceae were associated with prolonged response. The findings suggest that gut microbial composition may serve as a predictive biomarker of treatment efficacy.

Authors: Anna Grenda, Ewelina Iwan, Paweł Krawczyk, Arkadiusz Bomba, Izabela Chmielewska, Katarzyna Bielińska, Aleksandra Grzywna, Michał Szczyrek, Tomasz Jankowski, Robert Kieszko, Natalia Galant, Janusz Milanowski

📖 Read the full text:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/105103

Adres

Ulica Roentgena 5
Warsaw
02-781

Strona Internetowa

https://www.researchgate.net/journal/Oncology-in-Clinical-P

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Oncology in Clinical Practice umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Praktyka

Wyślij wiadomość do Oncology in Clinical Practice:

Skróty

Udostępnij

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Kategoria